FOXP3⁺ T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNF𝜶 Agents

Figure 1

Treg frequencies in peripheral blood (PB) of all IBD patients before and after anti-TNFα therapy (𝑛=32); HC = healthy controls (𝑛=8); 𝑃 values versus HC by 𝑡 test for independent samples, T0 versus T1 by 𝑡 test for paired samples.